SHIELDS MATTHEW (EVP, Global Operations) sold 61.9% of their position (16.20K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $532.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0001193125-26-257344
Officer· EVP, Global Operations
Since Mar 2026
-16.20K
Net shares
Net seller
$532.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.20K acquired · 32.39K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+16.20K
Price / share
—
Trade value
—
% of position
162.1%
6/3/2026
9.99K→26.18K
Ordinary Shares
Direct
Shares
−16.20K
Price / share
$32.87
Trade value
$532.33K
% of position
61.9%
6/3/2026
26.18K→9.99K
Total
Net shares
+0.00
Net value
-$532.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/3/2026 | M · Option Exercise | +16.20K | — | — | 162.1% | 9.99K | 26.18K |
| Ordinary Shares Direct | 6/3/2026 | S · Sale | −16.20K | $32.87 | $532.33K | 61.9% | 26.18K | 9.99K |
| Total | +0.00 | -$532.33K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
16.20K shares
Shares
−16.20K
Strike price
Held after
32.39K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares16.20K shares | 6/3/2026 | M · Option Exercise | −16.20K | — | 32.39K |